Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 33540-33541 [2016-12472]

Download as PDF 33540 Federal Register / Vol. 81, No. 102 / Thursday, May 26, 2016 / Notices finalizes the draft guidance dated October 2009. FDA encourages firms that market sugar cane-derived sweeteners or products that contain a sugar canederived sweetener to review the final guidance and consider whether the name under which the sweetener is declared in food labeling accurately describes its basic nature and characterizing properties, as required by the common or usual name regulation (21 CFR 102.5). As explained in the final guidance, our view is that products currently labeled as containing ‘‘evaporated cane juice’’ should be relabeled to use the name ‘‘sugar,’’ optionally accompanied by a truthful, non-misleading descriptor to distinguish the ingredient from other cane-based sweeteners. FDA would not object to the use of stickers to make this change until the next regularly scheduled label printing. II. Electronic Access Persons with access to the Internet may obtain the guidance at either https:// www.fda.gov/FoodGuidances or https:// www.regulations.gov. Use the FDA Web sites listed previously to find the most current version of the guidance. Dated: May 20, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–12402 Filed 5–25–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Office of the Secretary, Office of the Assistant Secretary for Health, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to CARB@hhs.gov. sradovich on DSK3TPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:47 May 25, 2016 Jkt 238001 Registration information is available on the Web site https://www.hhs.gov/ash/ carb/ and must be completed by June 18, 2016; all in-person attendees must pre-register by this date. Additional information about registering for the meeting and providing public comment can be obtained at https://www.hhs.gov/ ash/carb/ on the Meetings page. DATES: The meeting is scheduled to be held on June 21, 2016, from 10:00 a.m. to 5:00 p.m. ET, and June 22, 2016, from 9:00 a.m. to 4:00 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the Web site for the Advisory Council at https:// www.hhs.gov/ash/carb/ when this information becomes available. Preregistration for attending the meeting in person is required to be completed no later than June 18, 2016; public attendance at the meeting is limited to the available space. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, DC 20201. The meeting also can be accessed through a live webcast on the day of the meeting. For more information, visit https://www.hhs.gov/ash/carb/. FOR FURTHER INFORMATION CONTACT: Bruce Gellin, Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 260–6638; email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of HHS to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Advisory Council will provide advice, information, and recommendations to the Secretary of HHS regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for Combating Antibiotic-Resistant Bacteria and the National Action Plan for Combating Antibiotic-Resistant Bacteria. The Advisory Council shall function solely for advisory purposes. PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 In carrying out its mission, the Advisory Council will provide advice, information, and recommendations to the Secretary regarding programs and policies intended to preserve the effectiveness of antibiotics by optimizing their use; advance research to develop improved methods for combating antibiotic resistance and conducting antibiotic stewardship; strengthen surveillance of antibioticresistant bacterial infections; prevent the transmission of antibiotic-resistant bacterial infections; advance the development of rapid point-of-care and agricultural diagnostics; further research on new treatments for bacterial infections; develop alternatives to antibiotics for agricultural purposes; maximize the dissemination of up-todate information on the appropriate and proper use of antibiotics to the general public and human and animal healthcare providers; and improve international coordination of efforts to combat antibiotic resistance. On June 21, the public meeting will be dedicated to presentations from federal and non-federal stakeholders surrounding topic areas related to incentives for the development of vaccines, diagnostics, and therapeutics. On June 22, the meeting will focus on the topic of the environment and antibiotic-resistance, in addition to a presentation regarding the new guidance from the Food and Drug Administration for Industry #213, ‘‘New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions With Guidance for Industry #209.’’ The meeting agenda will be posted on the Advisory Council Web site at https://www.hhs.gov/ash/carb/ when it has been finalized. All agenda items are tentative and subject to change. Public attendance at the meeting is limited to the available space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Designated Federal Officer at the address/telephone number listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/ash/carb/. Members of the public will have the opportunity to provide comments prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public E:\FR\FM\26MYN1.SGM 26MYN1 Federal Register / Vol. 81, No. 102 / Thursday, May 26, 2016 / Notices comments should be sent in by midnight June 15, 2016, and should be limited to no more than one page. All public comments received prior to June 15, 2016, will be provided to Advisory Council members; comments are limited to two minutes per speaker. Dated: May 18, 2016. Bruce Gellin, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Deputy Assistant Secretary for Health. [FR Doc. 2016–12472 Filed 5–25–16; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of the Secretary, Office of Minority Health, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting will be open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should email OMH-ACMH@hhs.gov by June 17, 2016. Information about the meeting is available from the designated contact and will be posted on the Web site for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH Web site under the heading About OMH. DATES: The meeting will be held on Monday, June 20, 2016, from 9:00 a.m. to 5:00 p.m. and on Tuesday, June 21, 2016, from 9:00 a.m. to 1:00 p.m. ET. ADDRESSES: The meeting will be held at the Doubletree by Hilton Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. FOR FURTHER INFORMATION CONTACT: Dr. Minh Wendt, Designated Federal Officer, ACMH; Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240–453–8222, Fax: 240–453–8223; OMH-ACMH@ hhs.gov. sradovich on DSK3TPTVN1PROD with NOTICES SUMMARY: In accordance with Public Law 105–392, the ACMH was established to provide SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 18:47 May 25, 2016 Jkt 238001 advice to the Deputy Assistant Secretary for Minority Health in improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the Office of Minority Health. Topics to be discussed during this meeting will include strategies to improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities, as well as other related issues. Public attendance at this meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least fourteen (14) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to three minutes per speaker. Individuals who would like to submit written statements should mail or fax their comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Any members of the public who wish to have printed material distributed to ACMH committee members should submit their materials to the Designated Federal Officer, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business on Monday, June 13, 2016. Dated: May 5, 2016. Minh Wendt, Designated Federal Officer, ACMH, Office of Minority Health, U.S. Department of Health and Human Services. [FR Doc. 2016–12473 Filed 5–25–16; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0098] Agency Information Collection Activities: NAFTA Regulations and Certificate of Origin U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 60-Day Notice and request for comments; extension of an existing collection of information. AGENCY: U.S. Customs and Border Protection (CBP) of the Department of SUMMARY: PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 33541 Homeland Security will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: NAFTA Regulations and Certificate of Origin (Forms 434, 446, and 447). CBP is proposing that this information collection be extended with a change to the burden hours. There is no change to the information collected. This document is published to obtain comments from the public and affected agencies. DATES: Written comments should be received on or before July 25, 2016 to be assured of consideration. ADDRESSES: Written comments may be mailed to U.S. Customs and Border Protection, Attn: Tracey Denning, Regulations and Rulings, Office of Trade, 90 K Street NE., 10th Floor, Washington, DC 20229–1177. FOR FURTHER INFORMATION CONTACT: Requests for additional information should be directed to Tracey Denning, U.S. Customs and Border Protection, Regulations and Rulings, Office of Trade, 90 K Street NE., 10th Floor, Washington, DC 20229–1177, at 202– 325–0265. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13). The comments should address: (a) whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimates of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden including the use of automated collection techniques or the use of other forms of information technology; and (e) the annual cost burden to respondents or record keepers from the collection of information (total capital/startup costs and operations and maintenance costs). The comments that are submitted will be summarized and included in the CBP request for OMB approval. All comments will become a matter of public record. In this document, CBP is soliciting comments concerning the following information collection: Title: NAFTA Regulations and Certificate of Origin. OMB Number: 1651–0098. Form Number: CBP Forms 434, 446, and 447. E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 81, Number 102 (Thursday, May 26, 2016)]
[Notices]
[Pages 33540-33541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12472]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Secretary, Office of the Assistant Secretary for 
Health, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held of the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to CARB@hhs.gov. Registration information is available on the Web 
site https://www.hhs.gov/ash/carb/ and must be completed by June 18, 
2016; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at https://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on June 21, 2016, from 10:00 
a.m. to 5:00 p.m. ET, and June 22, 2016, from 9:00 a.m. to 4:00 p.m. ET 
(times are tentative and subject to change). The confirmed times and 
agenda items for the meeting will be posted on the Web site for the 
Advisory Council at https://www.hhs.gov/ash/carb/ when this information 
becomes available. Pre-registration for attending the meeting in person 
is required to be completed no later than June 18, 2016; public 
attendance at the meeting is limited to the available space.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, 
DC 20201.
    The meeting also can be accessed through a live webcast on the day 
of the meeting. For more information, visit https://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Bruce Gellin, Designated Federal 
Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 260-6638; email: CARB@hhs.gov.

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    On June 21, the public meeting will be dedicated to presentations 
from federal and non-federal stakeholders surrounding topic areas 
related to incentives for the development of vaccines, diagnostics, and 
therapeutics. On June 22, the meeting will focus on the topic of the 
environment and antibiotic-resistance, in addition to a presentation 
regarding the new guidance from the Food and Drug Administration for 
Industry #213, ``New Animal Drugs and New Animal Drug Combination 
Products Administered in or on Medicated Feed or Drinking Water of 
Food-Producing Animals: Recommendations for Drug Sponsors for 
Voluntarily Aligning Product Use Conditions With Guidance for Industry 
#209.'' The meeting agenda will be posted on the Advisory Council Web 
site at https://www.hhs.gov/ash/carb/ when it has been finalized. All 
agenda items are tentative and subject to change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Designated Federal Officer at the address/telephone number 
listed above at least one week prior to the meeting. For those unable 
to attend in person, a live webcast will be available. More information 
on registration and accessing the webcast can be found at https://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public

[[Page 33541]]

comments should be sent in by midnight June 15, 2016, and should be 
limited to no more than one page. All public comments received prior to 
June 15, 2016, will be provided to Advisory Council members; comments 
are limited to two minutes per speaker.

    Dated: May 18, 2016.
Bruce Gellin,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Deputy Assistant Secretary for Health.
[FR Doc. 2016-12472 Filed 5-25-16; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.